32 / 171
1
I
Financial statements
1.1
I
Income statement
(in thousands of euros)
Notes
12/31/2018
12/31/2017
Sales revenue
2.6.1
1,645,095
1,643,356
Changes in stock, finished products and production in progress
9,251
(884)
Total production
1,654,346
1,642,472
Other revenues(a)
39,641
26,661
Total operating revenues
1,693,987
1,669,133
Consumed goods
2.6.2
(464,424)
(443,119)
Other purchases and external expenses
2.6.3
(352,485)
(338,332)
Taxes and duties
(11,615)
(12,171)
Personnel expenses (including temporary workers)
2.6.4
(640,048)
(619,333)
EBITDA
225,416
256,178
Depreciation
(99,025)
(90,132)
Net provisions
9,166
5,352
Current operating profit (EBIT)
135,558
171,398
Non-recurring operating expenses
2.6.6
(13,693)
(7,329)
Non-recurring operating revenues
2.6.6
3,427
3,649
Operating profit
125,290
167,718
Financing expenses and revenue on cash
2.6.7
(2,503)
(2,421)
Revenue on cash
2.6.7
3,462
3,445
Financing expenses
2.6.7
(5,965)
(5,866)
Other interest revenue and expenses
2.6.7
7,847
(19,166)
Other financial items
2.6.7
42,635
60,852
Other interest expenses
2.6.7
(34,788)
(80,018)
Taxes (including CVAE (Tax on Companies’ Added Value))
2.6.8
(33,839)
(39,182)
Profit (loss) for the period
96,794
106,951
Attributable as company shareholders’ equity
92,069
107,965
Interest not granting control over the company
4,725
(1,014)
Earnings per share (in €)
2.6.9
1.73
2.04
Diluted earnings per share (in €)
2.6.9
1.72
2.02
(a) In order to provide readers of the financial statements with better information that is in accordance with international standards, in the 2018 financial statements
the Company has continued classifying revenues related to CIR (Research tax credit) as “Other Revenues”.
30 LISI 2018 FINANCIAL REPORT CONSOLIDATED FINANCIAL STATEMENTS 3